Option Care Health, Inc. $OPCH Shares Purchased by Teca Partners LP

Teca Partners LP raised its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 20.6% in the first quarter, Holdings Channel reports. The fund owned 691,098 shares of the company’s stock after acquiring an additional 117,893 shares during the period. Option Care Health comprises approximately 12.8% of Teca Partners LP’s holdings, making the stock its 3rd biggest position. Teca Partners LP’s holdings in Option Care Health were worth $18,604,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Durable Capital Partners LP increased its position in shares of Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Southpoint Capital Advisors LP acquired a new position in Option Care Health in the fourth quarter valued at about $95,580,000. Sumitomo Mitsui Trust Group Inc. bought a new stake in Option Care Health during the first quarter worth about $70,287,000. Norges Bank bought a new stake in Option Care Health during the fourth quarter worth about $61,787,000. Finally, Van Berkom & Associates Inc. bought a new stake in Option Care Health during the first quarter worth about $42,739,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on OPCH. TD Cowen cut their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a research note on Friday, May 1st. Barrington Research decreased their price target on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Morgan Stanley set a $28.00 price target on Option Care Health in a research report on Wednesday, May 6th. JPMorgan Chase & Co. dropped their price target on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $26.00 price objective on shares of Option Care Health in a research report on Friday, May 1st. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $30.08.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average price of $21.41 per share, with a total value of $783,820.10. Following the completion of the acquisition, the director directly owned 450,000 shares in the company, valued at approximately $9,634,500. This trade represents a 8.86% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO John Charles Rademacher acquired 12,500 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average price of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 73,264 shares of company stock valued at $1,548,316 over the last quarter. Corporate insiders own 1.70% of the company’s stock.

Option Care Health Stock Up 0.7%

Shares of NASDAQ:OPCH opened at $21.81 on Tuesday. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The firm has a market cap of $3.42 billion, a P/E ratio of 16.91, a P/E/G ratio of 1.20 and a beta of 0.65. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80. The company’s 50-day moving average price is $21.36 and its two-hundred day moving average price is $27.01.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the previous year, the firm posted $0.40 earnings per share. The company’s revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, research analysts forecast that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.